Synapse

← Clinical & Translational Immunology

Papers in Clinical & Translational Immunology

Page 7 · newest first

  1. Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cellsClinical & Translational Immunology · 2021
  2. Pervasive inflammatory activation in patients with deficiency in very‐long‐chain acyl‐coA dehydrogenase (VLCADD)Clinical & Translational Immunology · 2021
  3. Memory CD8⁺ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle‐cell trait childrenClinical & Translational Immunology · 2021
  4. Epigenetic programming underpins B‐cell dysfunction in peanut and multi‐food allergyClinical & Translational Immunology · 2021
  5. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patientsClinical & Translational Immunology · 2021
  6. LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicityClinical & Translational Immunology · 2021
  7. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Clinical & Translational Immunology · 2021
  8. Rheumatoid arthritis CD14⁺ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of diseaseClinical & Translational Immunology · 2021
  9. Interleukin‐18, IL‐18 binding protein and IL‐18 receptor expression in asthma: a hypothesis showing IL‐18 promotes epithelial cell differentiationClinical & Translational Immunology · 2021
  10. Generation of plasma cells and CD27 ⁻ IgD ⁻ B cells during hantavirus infection is associated with distinct pathological findingsClinical & Translational Immunology · 2021
  11. Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 ⁺ and CD8 ⁺ T‐cell protective responses to breast cancerClinical & Translational Immunology · 2021
  12. IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndromeClinical & Translational Immunology · 2021
  13. Extreme prematurity and sepsis strongly influence frequencies and functional characteristics of circulating γδ T and natural killer cellsClinical & Translational Immunology · 2021
  14. Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritisClinical & Translational Immunology · 2021
  15. Interleukin‐1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysisClinical & Translational Immunology · 2021
  16. Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platformClinical & Translational Immunology · 2021
  17. Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplantClinical & Translational Immunology · 2021
  18. Peripheral autoreactive CD8 T‐cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetesClinical & Translational Immunology · 2021
  19. TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4⁺ T cellsClinical & Translational Immunology · 2021
  20. IL‐33/ST2 axis deficiency exacerbates neutrophil‐dominant allergic airway inflammationClinical & Translational Immunology · 2021
  21. Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapyClinical & Translational Immunology · 2021
  22. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomesClinical & Translational Immunology · 2021
  23. Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort studyClinical & Translational Immunology · 2021
  24. Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitorsClinical & Translational Immunology · 2021
  25. Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activityClinical & Translational Immunology · 2021
  26. The immunological link between neonatal lung and eye diseaseClinical & Translational Immunology · 2021
  27. The up‐to‐date pathophysiology of Kawasaki diseaseClinical & Translational Immunology · 2021
  28. Increased GM‐CSF‐producing NCR ‐ ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel diseaseClinical & Translational Immunology · 2021
  29. SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisationClinical & Translational Immunology · 2021
  30. Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating diseaseClinical & Translational Immunology · 2021
  31. Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variantClinical & Translational Immunology · 2021
  32. RNA sequencing identifies global transcriptional changes in peripheral CD4+ cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitisClinical & Translational Immunology · 2021
  33. Perivascular macrophages create an intravascular niche for CD8 + T cell localisation prior to the onset of fatal experimental cerebral malariaClinical & Translational Immunology · 2021
  34. Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system diseaseClinical & Translational Immunology · 2021
  35. Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary DiseaseClinical & Translational Immunology · 2021
  36. Hypothesis: Febrile infection‐related epilepsy syndrome is a microglial NLRP3 inflammasome/IL‐1 axis‐driven autoinflammatory syndromeClinical & Translational Immunology · 2021
  37. Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?Clinical & Translational Immunology · 2021
  38. High sensitivity and specificity of a 5‐analyte protein and microRNA biosignature for identification of active tuberculosisClinical & Translational Immunology · 2021
  39. The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patientsClinical & Translational Immunology · 2021
  40. Repeated influenza vaccination provides cumulative protection from distinct H3N2 virusesClinical & Translational Immunology · 2021
  41. Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresClinical & Translational Immunology · 2021
  42. Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19Clinical & Translational Immunology · 2021
  43. Inflammation neuroscience: neuro‐immune crosstalk and interfacesClinical & Translational Immunology · 2021
  44. Autoimmunity elicited by the chemokine response to adenovirus vector vaccines may underlie vaccine‐induced immune thrombotic thrombocytopaenia: a hypothesisClinical & Translational Immunology · 2021
  45. Localised release of matrix metallopeptidase 8 in fatal cerebral malariaClinical & Translational Immunology · 2021
  46. Activity of the growth hormone‐releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis‐like granulomaClinical & Translational Immunology · 2021
  47. A novel computer vision‐based assessment of neutrophil chemotaxis in patients with severe infectionClinical & Translational Immunology · 2021
  48. Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assayClinical & Translational Immunology · 2021
  49. A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cellsClinical & Translational Immunology · 2021
  50. Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New ZealandClinical & Translational Immunology · 2021